South Africa grows share of global nuclear medicine market

Following the exit of a Canadian producer of key medical radioisotope molybdenum-99 (Mo-99), South African company NTP Radioisotopes has stepped into the supply gap and increased its global market share.   The global nuclear medicine market, which includes radioisotopes and medical equipment, was valued at over US$11-billion in 2016, and is now projected to reach nearly US$20-billion by 2021.   Nuclear medicine uses tiny amounts of radioactive isotopes (radioisotopes), mostly for medical ...